Lupin is prepping a $1B US deal spree; Protagonist raising $60M for trial work
→ Coming off of a $150 million deal to buy Symbiomix, Mumbai-based Lupin says it’s planning a $1 billion deal spree aimed at building …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
